Serum Institute gets DCGI nod for clinical trials | Audio Bulletin
ABP News Bureau
Updated at:
01 Jan 1970 05:30 AM (IST)
Download ABP Live App and Watch All Latest Videos
View In App
In a statement, the Health Ministry said, "Drugs Controller General of India has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India."